Health Sciences Authority orders removal of contaminated Rosabella moringa powder capsules

Salmonellosis is a notifiable disease under the Infectious Diseases Act, and those who are unwell with symptoms of salmonella infection after consuming the product should seek medical advice promptly, added the statement.

The CDA has alerted hospitals and is conducting surveillance with them to monitor for potential drug-resistant salmonella cases. The HSA is also monitoring any reports of local adverse events related to the issue.

Consumers are advised to immediately stop taking the affected lots and dispose of the product safely by placing bottles or the capsules in a sealed bag with general household waste.

They should not open the capsules or flush them down toilets and drains. Any surfaces or containers that have come into contact with the product should be carefully cleaned and sanitised to reduce the risk of cross-contamination.

The affected Rosabella brand moringa powder capsules have been labelled to support sleep, healthy joints and energy level.

Moringa supplements are generally marketed for their vitamin, protein and antioxidant content, and may be used by elderly individuals and pregnant or lactating women as natural supplements.

Extensively drug-resistant salmonella is resistant to multiple key antibiotics, leading to limited treatment options and increased risk of severe complications.

Symptoms of salmonella infection typically include fever, diarrhoea, nausea, vomiting, and stomach cramps. They usually develop six to 72 hours after consumption and can last four to seven days.

Some people, especially older adults aged 65 and above, pregnant women and people with weakened immune systems, may experience more severe illnesses that require medical treatment or hospitalisation.